History
  • No items yet
midpage
Ansagay v. Dow Agrosciences LLC
153 F. Supp. 3d 1270
D. Haw.
2015
Read the full case

Background

  • Dow manufactured and sold the pesticide Dursban TC (active ingredient: chlorpyrifos), registered with the EPA under FIFRA and sold with an EPA-approved label containing safety warnings and a warranty disclaimer.
  • From 1988–1991 Benjamin Ansagay applied Dursban TC frequently and admitted he did not wear the respirator recommended on the label; co-workers were allegedly told distributors claimed the product was safe and would “flush out.”
  • Ansagay later developed infertility, depression, and lung cancer and died in 2014; his wife (on behalf of herself, his estate, and their child) sued Dow in Hawaii state court asserting wrongful death, negligence, breach of warranties, strict product liability, defective design/testing/manufacture, and emotional distress claims.
  • Dow removed the case and moved for summary judgment arguing FIFRA preempts all state-law claims because compliance with state duties would conflict with FIFRA and EPA-approved labeling.
  • The court denied summary judgment, holding FIFRA does not preempt the asserted state-law claims under the controlling framework in Bates and related precedent.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether FIFRA preempts the state-law claims Ansagay: claims (negligence, strict liability, warranty, design/testing) do not impose additional labeling requirements and therefore are not preempted Dow: state tort duties would impose labeling/packaging requirements or otherwise make it impossible to comply with FIFRA/EPA-approved label Denied — most claims not preempted; FIFRA preempts only state requirements that impose labeling/packaging requirements additional to or different from FIFRA (Bates test)
Whether implied (impossibility) preemption applies Ansagay: Bates controls and preserves state-law claims; Mensing/Bartlett (FDCA cases) are distinguishable Dow: even if Bates, impossibility preemption (as in Mensing/Bartlett) should bar claims because federal law required sale with approved label Denied — Bates implicitly rejects broad impossibility preemption under FIFRA; Mensing/Bartlett inapplicable (different statutory regime and generic-drug context)
Whether express and implied warranty claims are preempted Ansagay: express warranty claims are contractual and not state-imposed labeling requirements; implied warranties likewise do not require label changes Dow: warranty claims conflict with FIFRA labeling/registration Denied — express warranty claims are not preempted; EPA allows certain warranty revisions without registration, so compliance not impossible
Whether a federally approved label conclusively establishes legal adequacy of warnings under Restatement §402A Ansagay: federal approval does not automatically immunize manufacturer from state-law defect or design claims Dow: an EPA-approved warning should bar claims under §402A or at least establish adequacy Denied — federal approval is not a categorical bar; adequacy remains a question for the law/fact framework and Bates preserves state law roles

Key Cases Cited

  • Wyeth v. Levine, 555 U.S. 555 (2009) (federal approval of labeling does not give manufacturers indefinite immunity from state-law duties; agency approval is not the final word on safety for all time)
  • Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996) (Congressional intent is the touchstone of preemption analysis; presumption against preemption)
  • Bates v. Dow Agrosciences LLC, 544 U.S. 431 (2005) (FIFRA’s express preemption limited to state labeling/packaging requirements that are additional or different; preserves broad state-law role for design, testing, warranty, and common-law claims)
  • Pliva, Inc. v. Mensing, 564 U.S. 604 (2011) (FDCA/generic-drug context holding that impossibility preemption applies where federal law forbids unilateral label changes by generic manufacturers)
  • Geier v. American Honda Motor Co., 529 U.S. 861 (2000) (state law may be preempted if it frustrates the federal law’s purpose)
  • Cipollone v. Liggett Group, Inc., 505 U.S. 504 (1992) (express preemption clauses guide courts to discern congressional intent regarding displacement of state law)
  • City of Columbus v. Ours Garage & Wrecker Serv., Inc., 536 U.S. 424 (2002) (when two statutory interpretations are plausible, adopt the one disfavoring preemption)
Read the full case

Case Details

Case Name: Ansagay v. Dow Agrosciences LLC
Court Name: District Court, D. Hawaii
Date Published: Dec 29, 2015
Citation: 153 F. Supp. 3d 1270
Docket Number: CIVIL NO. 15-00184 SOM/RLP
Court Abbreviation: D. Haw.